Comparative in-vitro activities of trovafloxacin, ciproflaxacin, of loxacin, fleroxacin and broad-spectrum β-lactams against aerobe blood culture isolates

This publication has 12 references indexed in Scilit:

• The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria
  Journal of Antimicrobial Chemotherapy, 1997
• Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections
  Antimicrobial Agents and Chemotherapy, 1997
• Antibacterial activity of trovafloxacin against gram-positive blood culture isolates from nosocomial infections
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci
  Journal of Antimicrobial Chemotherapy, 1996
• Activity of Quinolones against Gram-Positive Cocci
  Drugs, 1995
• Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes
  Antimicrobial Agents and Chemotherapy, 1994
• In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial
  Diagnostic Microbiology and Infectious Disease, 1994
• In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria
  Antimicrobial Agents and Chemotherapy, 1993
• In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone
  Antimicrobial Agents and Chemotherapy, 1993
• Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group
  Antimicrobial Agents and Chemotherapy, 1991